Sign In
Buy ARCT
$5.76
-0.160 (-2.70%)
At Close: Jul 31, 2026
7 “Perfect 10” Healthcare Stocks to Buy Now
04:15pm, Wednesday, 18'th Mar 2020
Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.
Global Equities Tumble on Fears Governments Will Need More Stimulus to Battle Coronavirus Effects
11:58am, Wednesday, 18'th Mar 2020
European stock markets and U.S. stocks futures are down sharply on Wednesday, as investors weigh up whether plans by governments to prevent a global recession from the coronavirus would be enough.
Mid-Afternoon Market Update: Dow Falls Over 2300 Points; BioNTech Shares Surge
06:34pm, Monday, 16'th Mar 2020
Toward the end of trading Monday, the Dow traded down 10.19% to 20,822.15 while the NASDAQ fell 9.87% to 7,097.62. The S&P also fell, dropping 9.73% to 7,108.79. South Korea...
10 Biggest Price Target Changes For Thursday
12:17pm, Thursday, 12'th Mar 2020
JP Morgan cut Workday Inc (NASDAQ: WDAY) price target from $190 to $175. Workday shares closed at $142.03 on Wednesday.
H.C. Wainwright raised the price target for Arcturus...
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
H.C. Wainwright Maintains Their Buy Rating on Arcturus Therapeutics (ARCT)
05:14pm, Wednesday, 04'th Mar 2020
In a report released today,
Ed Arce
from H.C. Wainwright maintained a
Buy
rating on Arcturus Therapeutics (
ARCT
–
Research Report
), with a price target of
$18.00
. The company’s shares closed la
CVS, UNH among premarket gainers
02:15pm, Wednesday, 04'th Mar 2020
Cellect Biotechnology (NASDAQ:APOP) +38% on Canndoc deal.Dynatronics (NASDAQ:DYNT) +28%.AIM ImmunoTech (NYSEMKT:AIM) +24% on recent announcements on Covid-19 front.Arcturus Therapeutics Holdings (NA
And the Covid-19 list keeps growing...
01:12pm, Wednesday, 04'th Mar 2020
Recent announcements on the COVID-19 front:Luminex (NASDAQ:LMNX): Working on two SARS-Cov-2 tests: NxTAG CoV Expanded Panel: should be available to ship to customers in a few weeks. Testing in China t
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
Baird likes drug wholesalers in premarket analyst action
12:58pm, Friday, 07'th Feb 2020
Arcturus Therapeutics (NASDAQ:ARCT) initiated with Buy rating and $19 (70% upside) price target at Guggenheim.BeyondSpring (NASDAQ:BYSI) initiated with Buy rating and $25 (45% upside) price target at
How Reginald Ruffin led Miles to Division II playoffs
03:50pm, Friday, 22'nd Nov 2019
The Golden Bears have won four Southern Intercollegiate Athletic Conference titles and twice earned a spot in the NCAA Division II playoffs during Ruffin’s tenure.
